• blocker
  • The recommended dosage depends on the type, strength, and form of beta blocker and the condition for which it is prescribed. (encyclopedia.com)
  • This research is looking at the effect of biobehavioral factors such as stress and whether these factors alter how the body responds to chemotherapy, one of the purposes of this study is to determine if the addition of a beta-blocker such as Propranolol (Inderal) is tolerable when given with chemotherapy in the treatment of newly diagnosed ovarian, fallopian tube, or primary peritoneal cancer. (clinicaltrials.gov)
  • The Investigator wishes to determine whether the use of beta-blocker drugs such as Inderal, might alter these behavioral factors by drawing blood prior to and after the administration of Inderal as well as giving behavioral questionaires at different time points. (clinicaltrials.gov)
  • In this study, the investigators therefore want to examine which beta-blocker might be the safest for COPD patients, as each work slightly differently. (clinicaltrials.gov)
  • The primary outcome for this study will be the difference from baseline in the change in Inspiratory Capacity (IC) from rest to isotime peak (i.e. same time point during endurance exercise test) between beta-blocker treatments at 4 weeks. (clinicaltrials.gov)
  • Cardioselective b1-adrenergic blocker. (wikipedia.org)
  • Moprolol is a beta-adrenergic antagonist, or beta blocker. (wikipedia.org)
  • A similar beta-blocker, metoprolol, that is very popular both overseas and in the US brought in an estimated €2.2 million in 2010 in Europe. (wikipedia.org)
  • agents
  • Pindolol has little to no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, pindolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action. (pharmacycode.com)
  • therapeutic
  • Equally, the similarity in the symptomatic, circulatory, and electrocardiographic response to the intravenous and oral preparations suggests that metabolic breakdown products are probably of therapeutic importance only in so far as they antagonize beta-receptor activity. (bmj.com)